161 related articles for article (PubMed ID: 38692010)
1. PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.
Zhang Y; Wang F; Huang Y
Clinics (Sao Paulo); 2024; 79():100367. PubMed ID: 38692010
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
4. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram.
Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Feng YN; Wang MZ
Acta Radiol; 2020 Sep; 61(9):1221-1227. PubMed ID: 31902220
[TBL] [Abstract][Full Text] [Related]
6. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
[TBL] [Abstract][Full Text] [Related]
7. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
[TBL] [Abstract][Full Text] [Related]
9. Brain Glioma Localization Diagnosis Based on Magnetic Resonance Imaging.
Jin Y; Peng H; Peng J
World Neurosurg; 2021 May; 149():325-332. PubMed ID: 32992057
[TBL] [Abstract][Full Text] [Related]
10. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
[TBL] [Abstract][Full Text] [Related]
11. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
12. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival.
Hilario A; Hernandez-Lain A; Sepulveda JM; Lagares A; Perez-Nuñez A; Ramos A
Neurocirugia (Astur : Engl Ed); 2019; 30(1):11-18. PubMed ID: 30143443
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
[TBL] [Abstract][Full Text] [Related]
15. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
17. DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival.
Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Wang MZ; Zhang H; Liang LH; Feng YN; Yang JH
Acad Radiol; 2020 Dec; 27(12):e263-e271. PubMed ID: 31983532
[TBL] [Abstract][Full Text] [Related]
18. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
20. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
